Sclerosing hemangioma is a rare lung tumor that is usually benign, and many people learn about it after a chest scan done for another reason. Early symptoms of sclerosing hemangioma can include cough, chest discomfort, or coughing up blood, but not everyone will have the same experience. Sclerosing hemangioma is most often found in adults, especially middle-aged women, and it can stay present for years before it is noticed. Sclerosing hemangioma is not usually life-threatening, and outlook is generally very good after treatment. Treatment is most often surgery to remove the growth, and follow-up care is used to check recovery.
How many people live with Sclerosing hemangioma?
Sclerosing hemangioma is very rare, but worldwide prevalence estimates are not consistently reported by a single authoritative source, so a reliable global number is not available. The same is true in the United States: published information comes mostly from individual case reports and small hospital series rather than population-wide counts, so no dependable U.S. estimate is available.
Overview
Sclerosing hemangiomaSymptoms
Sclerosing hemangioma often causes no symptoms and may be found by chance on a chest scan. When symptoms happen, people with sclerosing hemangioma may have a cough, chest discomfort, shortness of breath, or rarely cough up blood.
Outlook and prognosis
For most people, sclerosing hemangioma grows slowly and has an excellent outlook, especially after treatment. Many living with sclerosing hemangioma do well long term, though rare cases can come back or spread and need follow-up.
Causes and risk factors
Doctors do not know the exact cause of sclerosing hemangioma. It seems to arise from sporadic cell changes rather than lifestyle or environmental exposures. Sclerosing hemangioma is reported more often in middle-aged women, especially in East Asian populations.
Genetic influences
Genetics do not seem to play a major inherited role in sclerosing hemangioma. Most cases happen sporadically, meaning they are not usually passed down in families, and no clear inherited genetic cause has been confirmed.
Diagnosis
Sclerosing hemangioma is usually suspected after a chest X-ray or CT scan shows a lung nodule. Diagnosis of sclerosing hemangioma is confirmed by examining a biopsy or the tissue removed during surgery.
Treatment and drugs
Sclerosing hemangioma is usually treated by monitoring small, symptom-free tumors and removing larger or uncertain ones with surgery. Most people do well after treatment. Follow-up scans may be used to watch for rare recurrence.
Symptoms
Many people with Sclerosing hemangioma feel well and only learn about it after a chest scan done for another reason. When it does cause problems, the symptoms usually come from the lungs, such as cough, chest discomfort, or shortness of breath. The early symptoms of Sclerosing hemangioma can be mild and easy to miss. Symptoms vary from person to person and can change over time.
Many people with Sclerosing hemangioma have no symptoms at all. It is often found by chance when imaging is done for a different concern.
A cough can be dry or bring up a small amount of mucus. For many, it may linger for weeks and feel out of proportion to a simple cold.
Some people cough up streaks of blood or blood-tinged mucus. Even a small amount should be checked, because this symptom can have several causes besides Sclerosing hemangioma.
Some may notice a dull ache, pressure, or discomfort in the chest. This can be more noticeable with deep breaths, coughing, or activity.
How people usually first notice Sclerosing hemangioma?
Many people first notice sclerosing hemangioma only after a chest X-ray or CT scan done for another reason shows a small spot in the lung, because this tumor often causes no symptoms at all. When symptoms do happen, the first signs of sclerosing hemangioma are usually mild and nonspecific, such as a lingering cough, chest discomfort, shortness of breath, or occasionally coughing up blood. Because these early changes can look like much more common lung problems, doctors usually confirm what it is only after imaging and sometimes a biopsy, which means a small tissue sample is checked under a microscope.
Types of Sclerosing hemangioma
Sclerosing hemangioma usually does not have clear-cut clinical types the way some other conditions do. In practice, when doctors talk about the types of sclerosing hemangioma, they usually mean the tissue patterns seen under a microscope rather than different day-to-day symptom patterns. Many living with this condition have no symptoms at all, and when symptoms do happen, they are more often linked to the tumor’s size or location than to its tissue pattern.
Papillary pattern
This pattern has small finger-like growths when the tumor is examined in the lab. People with sclerosing hemangioma that shows this pattern usually do not have unique symptoms compared with other patterns.
Sclerotic pattern
This pattern contains more dense, scar-like tissue. It does not usually cause a distinct set of symptoms, although a larger growth in the lung can sometimes lead to cough, chest discomfort, or shortness of breath.
Solid pattern
This pattern looks more compact and cell-rich under the microscope. Symptoms are still often absent, and if problems occur they tend to relate to where the tumor sits rather than the solid pattern itself.
Hemorrhagic pattern
This pattern includes areas with more blood-filled spaces. Sometimes, symptoms cluster together in recognizable ways, and this pattern may be seen in tumors linked with coughing up blood, but many people still have no symptoms.
Can I slow down the onset of symptoms?
Probably not; there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms from sclerosing hemangioma, a rare and usually slow-growing lung growth. Healthy habits like not smoking and looking after your overall lung and heart health are still important, but they have not been shown to reduce the risk of this growth in a proven way or prevent symptoms from starting. If it has already been found, doctors usually focus on follow-up scans and, in some cases, surgery if it grows or causes problems, and many people do well with careful monitoring.
What genetics can tell you about symptoms
For sclerosing hemangioma, genetics usually cannot predict which symptoms someone will have, how severe they will be, or when they will start. Most people with this condition have no symptoms or only mild symptoms, and when symptoms do happen, they are more often related to the size and location of the growth than to inherited gene changes. Researchers have found some genetic changes in the tumor itself, but these findings are not yet used to forecast symptoms in everyday care.
Causes and risk factors
The exact cause of sclerosing hemangioma is not clear, but it appears to start from cells that line the small air spaces in the lung. It is seen most often in adults, especially women, so age and sex seem to affect risk. Researchers are still learning how these pieces fit together. No strong inherited gene cause has been confirmed, and most cases of sclerosing hemangioma do not run in families. Smoking, diet, and usual environmental exposures have not been proven to cause it, but your doctor may still review these when looking at possible lung growths.
What are the most common causes or risk factors?
The exact cause of sclerosing hemangioma is not known. It is usually not linked to smoking, and there is no strong proof that it runs in families, so a clear inherited cause has not been established. The main known risk pattern is that it is found most often in middle-aged women and has been reported more often in people of Asian background, and in many cases it is discovered by chance during a chest scan done for something else.
Environmental and biological risk factors
The main thing to know is that risk factors for sclerosing hemangioma are not well defined. Doctors often group risks into internal (biological) and external (environmental). For sclerosing hemangioma, most of what is known comes from patterns seen across reported cases rather than from a single confirmed cause. That means doctors can point to a few trends, but not to a clear set of proven triggers.
Sclerosing hemangioma is reported much more often in women than in men. This suggests sex-related biological factors may influence who develops it, although the exact reason is still unclear.
Many people with sclerosing hemangioma are diagnosed in adulthood, often in middle age. This pattern points to age-related biological factors, but the condition can appear outside this age range.
Reported cases have been seen relatively often in East Asian populations. It is not yet clear whether this reflects a true biological difference, where studies have been done, or differences in how often scans find the condition.
No specific environmental exposure has been consistently proven to cause sclerosing hemangioma. Smoking, infection, air pollution, and workplace exposures have not been confirmed as established risk factors.
Genetic risk factors
In sclerosing hemangioma, the genetic picture is still incomplete, and most cases seem to arise by chance rather than being passed down in families. If you are wondering about the genetic causes of sclerosing hemangioma, there is no single inherited gene that clearly explains most cases. Researchers have found gene changes inside some tumors, but these are usually acquired changes in the tumor itself, not changes a parent would pass on.
Inherited genes: No inherited gene has been proven to cause most cases of sclerosing hemangioma. Many living with this tumor do not have a clear family history of the same growth.
AKT1 changes: Some tumors have acquired changes in a gene called AKT1, which may help the tumor develop. These changes are usually limited to the tumor cells and are not thought to increase risk for relatives.
Family history: Family history is not considered a strong or well-established genetic risk factor for sclerosing hemangioma. People with the same risk factor can have very different experiences.
Lifestyle risk factors
Sclerosing hemangioma is not caused by lifestyle habits, but how lifestyle affects sclerosing hemangioma can matter for breathing symptoms, recovery after treatment, and the chance of complications. Most people are monitored or treated surgically, so the main lifestyle considerations relate to lung health and overall fitness rather than prevention. When people ask about lifestyle risk factors for sclerosing hemangioma, the practical focus is on habits that can worsen cough, shortness of breath, or recovery.
Smoking does not cause sclerosing hemangioma, but it can irritate the airways and make cough, breathlessness, or chest discomfort more noticeable. It can also increase surgical and anesthesia risks if the lung lesion needs to be removed.
Vaping can inflame the airways and reduce respiratory comfort in someone who already has a lung mass. This may make it harder to tell whether new symptoms are coming from the lesion itself or from airway irritation.
Regular activity can help maintain lung capacity, stamina, and recovery after chest surgery or a diagnostic procedure. If the tumor is causing shortness of breath, chest pain, or coughing up blood, exercise may need to be adjusted and guided by a clinician.
Carrying excess weight can worsen breathlessness and reduce exercise tolerance, which may add to symptoms from a lung lesion. A healthier weight can also lower the risk of complications during imaging, procedures, or surgery.
Risk prevention
Sclerosing hemangioma is a rare lung growth that usually cannot be prevented in a specific, proven way because its exact cause is not well understood. For many living with sclerosing hemangioma, prevention is mostly about lowering avoidable lung risks and getting unusual symptoms checked early. Different people need different prevention strategies—there’s no single formula.
There is no established way to fully prevent sclerosing hemangioma from forming. Because the cause is unclear, risk reduction focuses on overall lung health rather than a disease-specific step.
Not smoking and avoiding secondhand smoke may help protect lung tissue and lower the chance of other lung problems that can complicate care. If a scan later finds sclerosing hemangioma, healthier lungs can make monitoring or treatment easier.
Reducing exposure to dust, fumes, and workplace chemicals may support lung health, especially if you use masks or ventilation when needed. This has not been proven to prevent sclerosing hemangioma, but it can lower other avoidable lung strain.
A lingering cough, chest discomfort, coughing up blood, or shortness of breath should be assessed rather than ignored. Early review is important because the early symptoms of sclerosing hemangioma can overlap with many other lung conditions.
Can you prevent Sclerosing hemangioma?
No, there is no known way to prevent sclerosing hemangioma, which is a rare growth in the lung, because doctors still do not know exactly why it develops. It has not been clearly linked to lifestyle or environmental risk factors, so healthy habits are still good for your overall lung health but are not proven to stop this condition from happening.
Transmission
If you are wondering whether sclerosing hemangioma is contagious, the short answer is no. Sclerosing hemangioma does not spread from one person to another through coughing, close contact, sex, blood, food, or water, so it is not considered infectious.
For many living with sclerosing hemangioma, this means there is no risk of passing it to family members, coworkers, or other close contacts in daily life. It is also not usually thought of as an inherited condition, so there is no well-established genetic transmission of sclerosing hemangioma in most cases.
When to test your genes
For sclerosing hemangioma, genetic testing is not usually part of early detection or routine care, because diagnosis is mainly based on imaging and the tissue appearance under the microscope. Testing may be considered only if the tumor pattern is unusual or there is a strong family history suggesting an inherited syndrome.
Diagnosis
Sclerosing hemangioma is usually found after a lung spot shows up on a chest scan or causes mild symptoms such as a cough, chest discomfort, or coughing up blood. For many, the first step comes when everyday activities start feeling harder, or when an imaging test done for another reason picks up a small mass. The diagnosis of sclerosing hemangioma is based on imaging and then confirmed by examining a tissue sample under the microscope.
Doctors ask about symptoms, how long they have been present, and whether there have been repeated chest infections, bleeding, or shortness of breath. A physical exam may be normal, but it helps rule out more common causes of lung symptoms.
A chest X-ray may show a round lung nodule, but a CT scan gives a much clearer look at its size, shape, and exact location. These imaging findings can raise suspicion, although they cannot confirm sclerosing hemangioma on their own.
Your provider may suggest contrast-enhanced CT to look closer at how the lump takes up blood flow and whether nearby structures are involved. This helps doctors compare it with other causes of a solitary lung nodule, including lung cancer or benign growths.
If the growth is near the airways, doctors may perform bronchoscopy, using a thin flexible tube to look inside the lungs and sometimes collect cells or tissue. This can help in selected cases, but it does not always provide enough tissue for a firm diagnosis.
How is Sclerosing hemangioma diagnosed?
Doctors usually suspect sclerosing hemangioma after a chest imaging test, such as an X-ray or CT scan, shows a small round growth in the lung. To confirm what it is, they usually need a small tissue sample, or sometimes the whole lump is removed, so it can be checked under a microscope and told apart from lung cancer or other growths. Genetic testing is not usually needed to make the diagnosis.
Stages of Sclerosing hemangioma
Sclerosing hemangioma does not have defined progression stages. This is because it is usually a single, slow-growing lung growth rather than an illness that moves through predictable phases over time. Often the process begins when you notice changes in daily life, such as a cough that does not settle or a spot found by chance on a chest X-ray or CT scan while doctors are checking something else. Diagnosis is usually based on imaging, review of symptoms of sclerosing hemangioma, and often a tissue sample to confirm what the growth is and rule out other causes.
Outlook and prognosis
The outlook for people with sclerosing hemangioma is generally excellent, because this tumor is usually slow-growing and benign, and complete surgical removal is typically curative. Most patients remain disease-free for many years after resection, and recurrence is uncommon. Rare cases show lymph node involvement or very infrequent distant spread, but even then the clinical course is often indolent compared with malignant lung tumors. Death from sclerosing hemangioma is exceptionally rare, and overall life expectancy is usually not affected when the lesion is properly diagnosed and treated. Prognosis may be less favorable only in unusual cases with multifocal disease, incomplete removal, or diagnostic confusion with more aggressive lung neoplasms.
Long-term effects
For most people, the long-term outlook for sclerosing hemangioma is very good, especially when the growth has been fully removed. Many living with sclerosing hemangioma have few or no lasting problems and go back to usual daily life after treatment. It’s important to remember that long-term doesn’t always mean progressive. In a small number of cases, doctors continue follow-up over time because rare recurrences or spread to nearby lymph nodes have been reported.
Sclerosing hemangioma usually behaves as a low-grade lung tumor, so long-term survival is generally excellent. After complete treatment, many people do not develop major ongoing health problems from the tumor itself.
Even with a very good prognosis, some people need repeat scans over the years to make sure the tumor has not come back. This is because the long-term effects of sclerosing hemangioma can include rare recurrence, although that is uncommon.
If the tumor was large or surgery removed part of the lung, some may notice mild shortness of breath with exertion afterward. For many, this can mean getting winded a little faster on stairs or long walks, while others notice no lasting change.
A cough, chest discomfort, or occasional blood-streaked mucus may improve after treatment, but some people have lingering irritation for a time. These symptoms are more often tied to the lung and healing process than to aggressive tumor behavior.
How is it to live with Sclerosing hemangioma?
For many people, living with sclerosing hemangioma means living with uncertainty more than with day-to-day symptoms, because this rare and usually benign lung tumor is often found by accident on a chest scan done for another reason. Some people have no symptoms at all, while others may notice cough, chest discomfort, or rarely coughing up blood, and in those cases daily life can be shaped more by follow-up scans, clinic visits, and worry about what the diagnosis means than by physical limits. For family and close friends, the biggest effect is often emotional too: they may share the stress of a lung mass being discovered, even though the outlook after proper evaluation and treatment is usually very good.
Treatment and drugs
Sclerosing hemangioma is usually treated by watching it closely or removing it with surgery, depending on its size, where it is, and whether it is causing symptoms. Many people with sclerosing hemangioma feel well and learn about it after a scan done for another reason, but if the growth is getting bigger, causing cough, chest discomfort, or bleeding, surgery is often the main treatment. Treatment often looks different for each person, and doctors may recommend regular imaging over time for a small, stable growth or an operation to remove part of the lung if needed. Medicines such as chemotherapy or radiation are not usually the standard treatment for sclerosing hemangioma because it is most often a slow-growing, noncancerous lung tumor.
Can you cure Sclerosing hemangioma?
Yes, many people with sclerosing hemangioma can be cured if the growth is fully removed with surgery. It is usually a slow-growing, noncancerous lung growth, and when surgery is not needed right away, doctors may simply watch it closely and treat any symptoms or problems if they come up.
Non-drug treatment
Many living with sclerosing hemangioma feel well and learn about it after a scan done for something else, while others may have cough, chest discomfort, or rare episodes of coughing up blood. Because this tumor is usually slow-growing, non-drug care often centers on careful monitoring or a procedure to remove it, depending on its size, location, and symptoms. Not every approach works the same way, and the best plan usually comes from a chest specialist and surgeon reviewing the scans together.
If sclerosing hemangioma is small and not causing symptoms, regular chest scans and follow-up visits may be all that is needed. This helps doctors watch for growth or changes without rushing into treatment.
Surgery is the main non-drug treatment for sclerosing hemangioma when the lump is growing, causing symptoms, or the diagnosis is uncertain. Depending on where it sits in the lung, surgeons may remove just the nodule and a small rim of tissue or, less often, a larger section of lung.
Many people can have keyhole chest surgery rather than a larger open operation. For many, this can mean less pain, a shorter hospital stay, and a quicker return to daily activities.
After treatment, repeat imaging is often used to make sure the area is healing as expected and that no new concerns appear. This is a routine part of treatment for sclerosing hemangioma of the lung, even though the outlook is usually very good.
Your genes may have an impact on how drugs work for you
For most people living with sclerosing hemangioma, medicines are not the main treatment, so genes usually do not have a major, well-established role in day-to-day care. This growth in the lung is often managed with monitoring or surgery, and if medicine is used for related symptoms or around the time of treatment, natural differences in how the body breaks down drugs can sometimes change how well a medicine works or how likely side effects are. Still, gene-based drug testing is not a routine part of care for this condition, because there are no widely accepted medicine choices for sclerosing hemangioma where this has been clearly shown to guide treatment.
Pharmacological treatments
Most people with sclerosing hemangioma do not need a specific drug to shrink or remove the growth, because medication is not the standard treatment for sclerosing hemangioma. Medication can feel like a big step, but in this condition, medicines are usually used only to ease symptoms such as cough or chest discomfort, or to treat another problem found at the same time.
There is no established medicine that directly treats sclerosing hemangioma itself. When treatment is needed, doctors usually rely on monitoring or a procedure rather than routine drug therapy.
Acetaminophen or nonsteroidal anti-inflammatory drugs such as ibuprofen may be used if chest discomfort happens. These medicines do not treat the lesion, but they can help some people feel more comfortable day to day.
If sclerosing hemangioma is linked with cough, doctors may suggest a cough medicine such as dextromethorphan or benzonatate. The choice depends on how often the cough happens and whether another lung problem could also be contributing.
If there is a separate infection or another lung condition, medicines such as antibiotics may be used for that problem. In this setting, the drug is treating the complication, not sclerosing hemangioma itself.
Genetic influences
For sclerosing hemangioma, doctors do not usually see a strong inherited pattern, and most cases seem to happen sporadically rather than being passed from parent to child. It’s natural to ask whether family history plays a role. In the limited research available, gene changes found in the growth itself appear to be changes that developed over time in those cells, not changes a family is born with. This means that when people ask whether sclerosing hemangioma is hereditary, the answer is usually no, or at least not based on what is currently known. If several relatives have had unusual tumors or related health problems, a doctor may still review the family history and decide whether genetic counseling would be helpful.
Is Sclerosing hemangioma genetic?
Genetics do not seem to play a major inherited role in sclerosing hemangioma. Most cases happen sporadically, meaning they are not usually passed down in families, and no clear inherited genetic cause has been confirmed.
Having a genetic risk is not necessarily a diagnosis
Changes in genes, often called genetic variants, are a normal part of being human and are common in the general population. Most of these variants do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with sclerosing hemangioma, treatment often relies more on surgery or careful follow-up than on long-term medicines, so genetics usually does not change the main plan. Right now, there are no widely accepted gene-based drug choices specifically for sclerosing hemangioma, and routine pharmacogenetic testing is not a standard part of care. Not every difference in response is genetic, but your age, liver and kidney function, and other medicines can affect how you handle anesthesia, pain medicine, or other drugs used around a procedure. In uncommon situations, doctors may study the tissue to help confirm the diagnosis or learn more about how the growth is behaving, yet those results do not usually lead to a proven targeted medicine. If you are looking into how genetics affect treatment for sclerosing hemangioma, the current answer is that genetics has a limited role, while decisions are still based mostly on symptoms, the size and location of the growth, and your overall health.
Interactions with other conditions
People with sclerosing hemangioma often have no symptoms at all, so it may first come up during a scan done for another issue, such as a lingering cough, chest infection, or chest pain from a different cause. When symptoms do happen, they can overlap with other lung problems, including bronchitis, pneumonia, asthma, or chronic obstructive pulmonary disease, and having more than one diagnosis can make symptoms feel harder to untangle. For many, this can mean the early symptoms of sclerosing hemangioma are mistaken for a more common breathing condition, especially if there is cough, shortness of breath, or small amounts of blood in the sputum. In rare cases, if the growth is large or close to an airway, it can add to breathing trouble or repeated infections in that part of the lung. The reassuring part is that sclerosing hemangioma is usually a localized lung growth and is not known for causing the kind of body-wide complications seen with aggressive cancers. If you are living with another lung condition, your doctor may look carefully at scans and symptoms together to sort out what is coming from each problem.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Sclerosing hemangioma?
Sclerosing hemangioma, a rare usually noncancerous lung growth, can look a lot like other causes of a lung spot or symptoms such as cough, chest pain, or coughing up blood. The main conditions doctors often need to rule out are lung cancer, other slow-growing lung tumors such as carcinoid tumors, and harmless lung growths like hamartomas. Old infections or areas of lung scarring can also sometimes look similar on a chest scan.
History
People living with sclerosing hemangioma are often surprised to learn that the name has changed over time, because doctors once thought this growth came from blood vessels. In daily life, that kind of shift matters: an older scan report or pathology note may use one term, while a newer specialist may use another, even though they are talking about the same condition.
First described in the medical literature as a lung growth with both solid and blood-filled looking areas, sclerosing hemangioma was originally grouped with vascular tumors because of how it appeared under the microscope. As medical science evolved, doctors learned that this older label was misleading. The lesion is now more often called pulmonary sclerosing pneumocytoma, a name that better reflects what specialists believe about the kind of cells involved.
That change did not happen all at once. For years, pathologists debated exactly what sclerosing hemangioma was, because it can show a mix of patterns in the same tumor. Some parts may look firm and scar-like, others more papillary or blood-rich, which made early classification difficult. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Over time, better microscopy and laboratory staining methods helped doctors sort it out. What used to seem like a blood vessel tumor came to be understood as a usually benign lung tumor with distinctive cell types and a characteristic appearance on pathology. That matters for people with sclerosing hemangioma because it helps explain why the condition is often found by chance on imaging, and why the conversation today is usually about confirming the diagnosis and deciding on follow-up or treatment, rather than assuming an aggressive cancer.
In more recent years, awareness has also grown because chest imaging is used more often, so small lung nodules are found more frequently than in the past. This has made accurate naming and diagnosis even more important. Knowing the condition’s history can make older records less confusing and helps explain why you may still see both names used in medical documents.